{"text": ["Big", "Drug", "Stocks", "Have", "Rallied.", "Why", "an", "Analyst", "Says", "They", "Have", "More", "Room", "to", "Run."], "created_at": "2021-05-24 14:48:00"}
{"text": ["10", "Best", "Dividend", "Stocks", "to", "Buy", "According", "to", "Billionaire", "Mario", "Gabelli"], "created_at": "2021-05-24 13:40:10"}
{"text": ["AbbVie", "Presents", "New", "Late-Breaking", "Data", "Analyses", "Showing", "Risankizumab", "(SKYRIZI\u00ae)", "", "Achieves", "Clinical", "Remission", "and", "Endoscopic", "Response", "at", "Week", "12", "in", "Patients", "with", "Moderate", "to", "Severe", "Crohn's", "Disease"], "created_at": "2021-05-24 13:15:00"}
{"text": ["The", "Lancet", "Publishes", "Results", "from", "Pivotal", "Global", "Phase", "3", "Program", "Evaluating", "RINVOQ\u00ae", "(upadacitinib)", "in", "Atopic", "Dermatitis"], "created_at": "2021-05-24 12:45:00"}
{"text": ["JNJ's", "Stelara", "Fails", "to", "Beat", "AbbVie's", "Humira", "In", "Crohn's", "Disease", "Patients"], "created_at": "2021-05-24 12:16:03"}
